Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours Β· Estimated delivery Aug 16 - Aug 21
Hatonen, K.A
When appetite is suppressed and you can only manage small amounts of food, the nutritional quality of every bite matters enormously
FLOW vs AWARD-7 vs LEADER Renal Substudy: GLP-1 Receptor Agonists and Kidney Outcomes Compared At a Glance At a glance | Feature | FLOW (Perkovic 2024) | AWARD-7 (Tuttle 2018) | LEADER Renal Substudy (Mann 2017) | |---|---|---|---| | Drug | Semaglutide 1.0 mg SC weekly | Dulaglutide 0.75 mg or 1.5 mg SC weekly | Liraglutide 1.8 mg SC daily | | N | 3,533 | 577 | 9,340 (full trial)
INDICATIONS: Peripheral neuropathy Chronic fatigue syndrome Diabetic neuropathy Cardiovascular support Muscle recovery and fatigue management*
There were no differences in levels of S-glutathionylated proteins (GSSP) among groups (Fig
